欧洲血浆分离市场预测至 2028 年 - COVID-19 影响和按产品(免疫球蛋白、白蛋白、凝血因子浓缩物、蛋白酶抑制剂和其他血浆产品)、应用(神经学、免疫学、血液学、重症监护、肺病学等)进行区域分析应用程序)和最终用户(医院和诊所、临床研究实验室和学术机构)

TIPRE00026271 | Pages: 133 | Medical Device | Dec 2021 | Type: Regional | Status: Published

市场介绍

欧洲血浆分馏市场包括德国、法国、英国、西班牙、意大利和欧洲其他国家。欧洲在全球血浆分离市场中占据重要地位,预计在预测期内将出现强劲的增长率。由于人口老龄化、越来越多地使用免疫球蛋白来治疗各种慢性疾病、免疫和出血性疾病的患病率增加以及用于疾病管理的血浆疗法的激增,预计该地区的市场将增长,这些都预计将推动欧洲地区的市场增长。

在欧洲国家,神经系统疾病、血液系统疾病、呼吸系统疾病等各种慢性疾病的医疗实践已经发生了变化。由于医务人员的多元化以及集中治疗危重病人的决定,COVID-19 的上升影响了疾病的发现和治疗。由于当前的大流行,许多研究机构更加关注COVID-19研究,并努力更好地了解该病毒。该地区的一些联邦机构已主动采用血浆疗法来治疗 COVID-19 患者。例如,法国国家药品和保健品安全局(ANSM)宣布将使用免疫血浆疗法治疗重症患者。此外,欧盟委员会建议紧急使用恢复期血浆疗法来治疗危重患者。因此,在 COVID-19 管理中使用血浆疗法在一定程度上对市场产生了积极影响。然而,由于 COVID-19,神经系统疾病、血液疾病和特质性疾病的整体医疗实践发生了变化,大多数制药和生物制药公司都在强调开发针对 COVID-19 的新型治疗疗法,这对市场增长。                

< p>市场概况和动态

欧洲血浆分离市场预计将从2021年的68.2467亿美元增长到2028年的104.0295亿美元;预计 2021 年至 2028 年复合年增长率为 6.2%。老年人口数量不断增加,免疫球蛋白在神经病学、血液学、罕见遗传性疾病和自身免疫性疾病等各个治疗领域的使用不断增加,以及对血浆衍生疗法的管理需求不断增长预计所有疾病都将推动欧洲其他地区的血浆分离市场。此外,欧洲的多家公司正在加大对研发活动的投资,以开发和推出用于疾病管理的血浆疗法的新方法。     

主要细分市场

欧洲血浆分离市场分为产品、应用、最终用户和国家。欧洲血浆分离市场根据产品分为免疫球蛋白、白蛋白、凝血因子浓缩物、蛋白酶抑制剂等。免疫球蛋白细分市场可能会在 2021 年占据最大的市场份额。欧洲血浆分离市场根据应用分为神经病学、免疫学、血液学、重症监护、肺病学等。 2021 年,神经病学领域可能会占据最大的市场份额。欧洲血浆分离市场根据最终用户分为医院和诊所、临床研究实验室、学术机构。 2021年,医院和诊所部门可能会占据最大的市场份额。根据国家/地区,欧洲血浆分离市场分为法国、德国、意大利、西班牙、英国和欧洲其他地区。欧洲其他地区在 2021 年占据最大的市场份额。

主要来源和上市公司

准备本欧洲血浆分离市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有 Bharat Serums and Vaccines Limited (BSV);生物制品实验室有限公司;生物测试公司; CSL有限公司;格里福尔斯,SA; Kedrion SpA;奥克塔制药公司;桑昆;和 SK 等离子。          

购买报告的理由

  • 了解欧洲血浆分馏市场格局并确定最有可能保证血浆分馏市场的细分市场强劲回报。
  • 了解欧洲血浆分馏市场不断变化的竞争格局,保持领先地位。
  • 通过识别最有可能销售前景的细分市场,有效规划欧洲血浆分馏市场的并购和合作交易。
  • 通过敏锐而全面的分析,帮助做出明智的业务决策欧洲血浆分馏市场各个细分市场的市场表现。
  • 获取欧洲地区 2021-2028 年各个细分市场的市场收入预测

欧洲血浆分馏市场细分

欧洲血浆分馏市场 - 按产品

  • 免疫球蛋白
    • 静脉注射免疫球蛋白(IVIG)
    • 皮下免疫球蛋白(SCIG)
  • 白蛋白
  • 凝血因子浓缩物
  • 蛋白酶抑制剂
  • 其他

欧洲血浆分馏市场 - 作者:应用

  • 神经病学
  • 免疫学
  • 血液学
  • 重症监护
  • 肺病学
  • 其他

欧洲血浆分馏市场 - 按最终用户划分

  • 医院和诊所
  • 临床研究实验室
  • 学术机构

欧洲血浆分馏市场 - 按国家/地区

  • 法国
  • 德国
  • 意大利
  • 西班牙
  • 英国
  • 欧洲其他地区

欧洲血浆分馏市场 - 公司简介

  • Bharat Serums and Vaccines Limited (BSV)
  • Bio Products Laboratory Ltd.
  • Biotest AG。
  • CSL有限公司
  • Grifols,SA
  • Kedrion SpA
  • Octapharma AG
  • Sanquin
  • SK 等离子

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Plasma Fractionation Market – By Product

1.3.2        Europe Plasma Fractionation Market – By Application

1.3.3        Europe Plasma Fractionation Market – By End User

1.3.4        Europe Plasma Fractionation Market – By Country

2.           Europe Plasma Fractionation Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Plasma Fractionation Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Plasma Fractionation Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Plasma Therapy Being Widely Used

5.1.2        Market is Developing Due to Active Participation of the Key Players

5.2         Market Restraints

5.2.1        Alternate Non-Plasma Substitutes Available

5.3         Future Trends

5.3.1        Novel Diseases Getting Treated By Using Plasma Therapy

5.4         Impact Analysis

6.           Plasma Fractionation Market – Europe Analysis

6.1         Europe Plasma Fractionation Market Revenue Forecast and Analysis

7.           Europe Plasma Fractionation Market Revenue and Forecasts To 2028– by Product

7.1         Overview

7.2         Europe Plasma Fractionation Market, By Product 2021 & 2028 (%)

7.3         Immunoglobulin

7.3.1        Overview

7.3.2        Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.1          Intravenous Immunoglobulin (IVIG)

7.3.2.1.1          Overview

7.3.2.1.2          Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.2          Subcutaneous Immunoglobulin (SCIG)

7.3.2.2.1          Overview

7.3.2.2.2          Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.4         Albumin

7.4.1        Overview

7.4.2        Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.5         Coagulation Factor Concentrates

7.5.1        Overview

7.5.2        Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.6         Protease Inhibitors

7.6.1        Overview

7.6.2        Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.7         Other Plasma Products

7.7.1        Overview

7.7.2        Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

8.           Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – Application

8.1         Overview

8.2         Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)

8.3         Neurology

8.3.1        Overview

8.3.2        Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Immunology

8.4.1        Overview

8.4.2        Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Hematology

8.5.1        Overview

8.5.2        Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Critical Care

8.6.1        Overview

8.6.2        Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.7         Pulmonology

8.7.1        Overview

8.7.2        Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.8         Other Applications

8.8.1        Overview

8.8.2        Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.           Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – End User

9.1         Overview

9.2         Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Clinical Research Laboratories

9.4.1        Overview

9.4.2        Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.5         Academic Institutes

9.5.1        Overview

9.5.2        Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

10.        Europe Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis

10.1      Overview

10.1.1     Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)

10.1.1.1       Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       Germany: Plasma Fractionation Market, by Product– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3.1    Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)

10.1.1.1.4       Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.5       Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2       France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3.1    France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.4       France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.5       France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3       UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3.1    UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.4       UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5       UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4       Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1       Overview

10.1.1.4.2       Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3       Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3.1    Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.4       Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.5       Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5       Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1       Overview

10.1.1.5.2       Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3       Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3.1    Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.4       Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.5       Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6       Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3       Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3.1    Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.4       Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.5       Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on Europe Plasma Fractionation Market

11.1      Europe: Impact Assessment Of COVID-19 Pandemic

12.        Plasma Fractionation Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Followed by Major Market Players (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic developments

12.4.1     Overview

13.        Company Profiles

13.1      Biotest AG.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Octapharma AG

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Kedrion S.p.A

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      CSL Limited

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Grifols, S.A.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Bio Products Laboratory Ltd.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Sanquin

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Bharat Serums and Vaccines Limited (BSV)

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      SK Plasma

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Germany: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)

Table 3.             Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5.             France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 6.             France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 7.             France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 8.             France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 9.             UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 10.          UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 12.          UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 19.          Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Organic Developments Done By Companies

Table 26.          Inorganic developments done by Companies

Table 27.          Glossary of Terms, Plasma Fractionation Market

 


LIST OF FIGURES

Figure 1.           Europe Plasma Fractionation Market Segmentation

Figure 2.           Europe Plasma Fractionation Market Segmentation, By Country

Figure 3.           Europe Plasma Fractionation Market Overview

Figure 4.           Immunoglobulin Segment Held the Largest Share of the Product Segment in Europe Plasma Fractionation Market

Figure 5.           Germany to Show Significant Growth During Forecast Period

Figure 6.           Europe and PEST Analysis

Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to Europe Plasma Fractionation Market

Figure 8.           Europe Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028

Figure 9.           Europe Plasma Fractionation Market, by Product 2021 & 2028 (%)

Figure 10.        Europe Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        Europe Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        Europe Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        Europe Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 16.        Europe Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)

Figure 18.        Europe Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 19.        Europe Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 20.        Europe Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 21.        Europe Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 22.        Europe Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 23.        Europe Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 24.        Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)

Figure 25.        Europe Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 26.        Europe Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 27.        Europe Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 28.        Europe: Plasma Fractionation Market, by Key Country – Revenue (2021) (USD Million)

Figure 29.        Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)

Figure 30.        Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.        France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32.        UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Impact of COVID-19 Pandemic in European Country Markets

Figure 37.          Growth Strategies Followed by Major Market Players (%)
  1. Bharat Serums and Vaccines Limited (BSV)
  2. Bio Products Laboratory Ltd.
  3. Biotest AG.
  4. CSL Limited
  5. Grifols, S.A.
  6. Kedrion S.p.A
  7. Octapharma AG
  8. Sanquin
  9. SK Plasma
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe plasma fractionation market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000